| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/21/2013 | CN101421258B Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 08/21/2013 | CN101193862B Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 08/20/2013 | US8513420 Amino-naphthyridine derivatives |
| 08/20/2013 | US8513419 N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors |
| 08/20/2013 | US8513292 Compositions and methods for the treatment of cancer |
| 08/20/2013 | US8513277 Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof |
| 08/20/2013 | US8513276 Imidazo[1,2-a]pyridine compounds for use in treating cancer |
| 08/20/2013 | US8513270 Substituted heterocycles as Janus kinase inhibitors |
| 08/20/2013 | US8513262 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 08/20/2013 | US8513250 Imidazolo-heteroaryl derivatives with antibacterial properties |
| 08/20/2013 | US8513246 Use of N-heterocyclylmethylbenzamides in therapeutics |
| 08/20/2013 | US8513232 Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands |
| 08/20/2013 | US8513222 Methods of treating fibrosis, cancer and vascular injuries |
| 08/20/2013 | CA2608214C Quinoline derivatives as ep4 antagonists |
| 08/20/2013 | CA2584170C Phenylurea derivatives as inhibitors of tyrosine kinases for the treatment of tumour diseases |
| 08/15/2013 | WO2013120081A1 1h- pyrrolo [2, 3 -b] pyridine derivatives and their use as radical quenchers |
| 08/15/2013 | WO2013119625A1 Methods for the preparation of hiv attachment inhibitor piperazine prodrug compound |
| 08/15/2013 | WO2013119328A1 Solid state forms of apixaban |
| 08/15/2013 | WO2013119040A1 Compounds as inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 08/15/2013 | WO2013118986A1 Triazolopyridine derivatives as a tyrosine kinase inhibitor |
| 08/15/2013 | WO2013118086A1 Process for manufacturing a naphthyridine derivative |
| 08/15/2013 | WO2013117986A1 Pyrroloquinoline alkaloids as antimalarial agents and process for the preparation thereof |
| 08/15/2013 | WO2013117649A1 Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases |
| 08/15/2013 | WO2013117645A1 Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases |
| 08/15/2013 | WO2013117615A1 Piperidino-pyrimidine derivatives for the treatment of viral infections |
| 08/15/2013 | WO2013117610A1 Process for the preparation of 2-phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives |
| 08/15/2013 | WO2013116956A1 Tetracene tetracarboxylic diimides and their preparation |
| 08/15/2013 | WO2013116948A1 Indolizine derivatives |
| 08/15/2013 | WO2013096496A3 Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 08/15/2013 | US20130211090 Method for the production of 5-fluoro-1h-pyrazolo[3,4-b]pyridine-3-carbonitrile |
| 08/15/2013 | US20130211074 Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them |
| 08/15/2013 | US20130211073 Synthetic voacangine |
| 08/15/2013 | US20130210858 Sulfamoyl benzoic acid heterobicyclic derivatives as trpm8 antagonists |
| 08/15/2013 | US20130210857 Inhibitors of Human Immunodeficiency Virus Replication |
| 08/15/2013 | US20130210837 Compounds and Their Use as BACE Inhibitors |
| 08/15/2013 | US20130210832 1h-imidazo[4,5-c]quinolines |
| 08/15/2013 | US20130210827 Novel benzenesulfonamides as calcium channel blockers |
| 08/15/2013 | US20130210819 Quinazoline derivatives |
| 08/15/2013 | US20130210818 Novel Heterocyclic Compounds and Uses Thereof |
| 08/15/2013 | US20130210816 Fused-imidazoyl compounds useful as antimicrobial agents |
| 08/15/2013 | US20130210814 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses |
| 08/15/2013 | US20130210806 Tricyclic indole derivatives useful endothelial lipase inhibitors |
| 08/15/2013 | US20130210805 Quinazolinone-type compounds as crth2 antagonists |
| 08/15/2013 | US20130210804 Tricyclic mglur5 receptor modulators |
| 08/15/2013 | US20130210803 Fused tetracyclic pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use |
| 08/15/2013 | US20130210802 Imidazopyridines syk inhibitors |
| 08/15/2013 | US20130210796 Tetrazole compounds as calcium channel blockers |
| 08/15/2013 | US20130210768 Positive allosteric modulators of mglur2 |
| 08/15/2013 | US20130210721 Novel 3-hydroxyisothiazole 1-oxide derivatives |
| 08/15/2013 | US20130210625 Spiroheterocyclic pyrrolidine derivatives based pesticides |
| 08/15/2013 | US20130210615 Metal complex, modified compound thereof and useful compound thereof |
| 08/15/2013 | US20130209400 Pyrazole derivatives as jak inhibitors |
| 08/14/2013 | EP2626359A1 Perylene diimides |
| 08/14/2013 | EP2626354A1 Viral polymerase inhibitors |
| 08/14/2013 | EP2626348A1 Heterocyclic amides as rock inhibitors |
| 08/14/2013 | EP2626346A1 Benzo[k]fluoranthene derivative and organic electroluminescence element containing same |
| 08/14/2013 | EP2625178A1 Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls |
| 08/14/2013 | EP2625169A1 Quinazoline compounds as sodium channel blockers |
| 08/14/2013 | DE102012003065A1 New bivalent gamma-carboline derivatives, useful as anti-dementia drugs, cognition enhancers and/or substance for increasing memory capacity |
| 08/14/2013 | DE102012002678A1 Preparing substituted perylene-3,4-dicarboxylic acid anhydride compounds useful e.g. as dyes, comprises decarboxylating substituted perylene-tetracarboxylic acid-bisanhydride compounds using copper powder and amines, preferably 3-picoline |
| 08/14/2013 | CN103249734A Dyeing composition comprising a fatty substance, a pyrazolopyridine oxidation base and a coupler |
| 08/14/2013 | CN103249733A Fused triazoles for the treatment or prophylaxis of mild cognitive impairment |
| 08/14/2013 | CN103249732A Bacteria topoisomerase II inhibiting 2-thylcarbamoylamino-1, 3-benzothiazol-5-yls |
| 08/14/2013 | CN103249721A Arylamide derivatives as TTX-S blockers |
| 08/14/2013 | CN103242339A Heterocyclic compound and organic light-emitting diode including the same |
| 08/14/2013 | CN103242312A Method for preparing binary perylene diimide derivative efficiently |
| 08/14/2013 | CN103242311A Salts of pyridinopyrazine derivatives |
| 08/14/2013 | CN103242310A Pyrazolo pyridone compound and its application in preparation of anticoagulant |
| 08/14/2013 | CN103242174A Amine-based compound and organic light-emitting diode including the same |
| 08/14/2013 | CN102264736B Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors |
| 08/14/2013 | CN101883772B Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| 08/14/2013 | CN101827844B Imidazo [1,2-a] pyridine derivatives useful as ALK inhibitors |
| 08/14/2013 | CN101687796B Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 08/14/2013 | CN101679431B Method for preparation of enantiomer of tetracyclic benzazepine |
| 08/14/2013 | CN101460495B Compound having heterocyclic ring |
| 08/14/2013 | CN101437816B 2-aminopyridine analogs as glucokinase activators |
| 08/13/2013 | US8507683 Compounds for the treatment of hepatitis C |
| 08/13/2013 | US8507682 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors |
| 08/13/2013 | US8507521 Heterocyclic derivatives |
| 08/13/2013 | US8507500 Inhibiting neurotransmitter reuptake |
| 08/13/2013 | US8507487 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor |
| 08/13/2013 | US8507484 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases |
| 08/13/2013 | US8507473 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders |
| 08/13/2013 | US8507472 Bicyclic pyridinylpyrazoles |
| 08/13/2013 | US8507469 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| 08/13/2013 | US8507443 Anticancer agent |
| 08/13/2013 | CA2670892C Substituted diazepan compounds as orexin receptor antagonists |
| 08/08/2013 | WO2013116413A1 Diazabicyclo[3.3.1]nonanes, methods of synthesis, and uses thereof |
| 08/08/2013 | WO2013116291A1 Imidazo [4, 5 - b] pyridine derivatives as alk and jak modulators for the treatment of proliferative disorders |
| 08/08/2013 | WO2013116182A1 Heterocyclic compounds as inhibitors of leukotriene production |
| 08/08/2013 | WO2013115535A1 Novel crystalline acid addition salt of tricyclo derivative compound or hydride thereof, and production method therefor |
| 08/08/2013 | WO2013114332A1 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives |
| 08/08/2013 | WO2013114250A1 Benziimidazole and imidazopyridine derivatives as sodium channel modulators |
| 08/08/2013 | WO2013114113A1 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors |
| 08/08/2013 | WO2013113860A1 Fused pyrroledicarboxamides and their use as pharmaceuticals |
| 08/08/2013 | WO2013113715A1 Fungicidal pyrimidine compounds |
| 08/08/2013 | WO2013113669A1 Isoquinoline and naphthyridine derivatives |
| 08/08/2013 | WO2013113097A1 Cyclic molecules as bruton's tyrosine kinase inhibitors |
| 08/08/2013 | US20130203992 Methods for the preparation of hiv attachment inhibitor piperazine prodrug compound |
| 08/08/2013 | US20130203987 Ampk-activating heterocyclic compounds and methods for using the same |